Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

NCT00965341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Testosterone
DRUG: Placebo

Sponsor

M.D. Anderson Cancer Center